BGI and Diagenode will collaborate to develop standard methods in sample prep for next-generation sequencing for epigenetics research, the companies said today.

Under the deal, Diagenode will provide BGI with early access to its developments in chromatin- and DNA methylation-analysis methods and tools. The company is aiming to "increase the consistency and precision" of its epigenetic sample-prep assays for next-gen sequencing, including its ChIP, MeDIP, methyl-CpG biding domain protein capture, bisulfite conversion, and DNA fragmentation assays.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.